The human papilloma virus (HPV) vaccine is widely viewed as an effective way to protect women from both cervical cancer and genital warts. But doctors suspect the high cost and inconvenience associated with the vaccine, which consist of three shots given over the course of six months, may be preventing women and young girls from receiving it.